Excellence with Morality
RSS Feed
HomePeneliti Keyword Tahun
Kedokteran | Kedokteran Gigi | Hukum | Ekonomi & Bisnis | Farmasi | Kedokteran Hewan | I Sosial & I Politik | Fakultas Sains dan Teknologi | Kesehatan Masyarakat | Psikologi | Ilmu Budaya | Keperawatan | Perikanan & Kelautan |
Biografi Dosen
Nama Peneliti
Askandar Tjokroprawiro
Nama
Prof. Dr. H. Askandar Tjokroprawiro, dr.,Sp.PD, K-EMD
Tempat/Tanggal Lahir
Kediri / 22-07-1939
Nip
139080870
NIDN
0022073901
Jab.Fungsional/Struktural
Guru Besar | -
Fakultas
Kedokteran
Departemen
Ilmu Penyakit Dalam
Alamat Kantor
Jl. Dharmahusada 164 Sby, telp. 0811316449
Alamat Tinggal
JL. Raya Dharmahusada Indah No. 44 Sby., telp. 5947793
E-mail
diabetes@rad.net.id
Pendidikan Terakhir
S3
Bidang Keahlian
Ilmu Penyakit Dalam
Penelitian
- Respons Imunopatobiologis Mukosa Mulut Untuk Mengungkap Imunopatobiogenesis Infeksi Candida Albicans Pada Penderita Diabetes Mellitus 2000/31
- Antioxidant Potential Of The Extract Of Green Tea (camellia Sinensis) And Red Tea (hibiscus Sabdariffa) In Atherogenesis Process In Rats With Atherogenic Diet 2008/53
- Plasma Clotting Factors And Antithrombin Iii In Poorly Controlled Diabetes Mellitus 0/0
- Program Penyuluhan Diabetes Di Pusat Diabetes & Nutrisi Rsud Dr. Sutomo Fk Unair Surabaya, Indonesia 1996/5
- Mitochondrial Dna Mutations Associated With Diabetes Mellitus In Indonesia 1999/1
- Mitochondrial Dna Mutation Among Diabetes In Indonesia 1999/1
- The A3243g Mitochondrial Dna Mutations Does Not Play An Important Role In The Pathogenes Of Type 2 Diabetes Mellitus In Indonesia 2002/1
- G3316a And T3394c Mtdna Mutations As Predisposing Factors For Type 2 Diabetes Mellitus 2004/1
- The Survival And Mortality Of Diabetic Nephropathy 1990/1
- Diabetes In The Elderly 1990/1
- Clinical Pattern Of Diabetics Ouppatients In Department Of Internal Medicine, Dr.soetomo Hospital During 1986 1988 1990/1
- Diabetes Mellitus In Dr. Sutomo Hospital Surabaya 1989/1
- Diabetes Education Program In Diabetes Nutrition Center, Surabaya, Indonesia 1996/1
- Intra Observer Agreement On Semmes Weinstein Monofilament Test In Non Insulin Dependent Diabetes Mellitus 1996/1
- Cardiovascular Complications In Diabetes Study In 579 Diabetic Patients In Surabaya 1996/1
- The Presence Of Obesity, Hypertension, And Metabolic Disorder Related To Diabetes Mellitus With G3316a And T3394c Mitochondrial Dna Mutation 2004/2
- Hubungan Antara Retinopati Dengan Keterbatasan Gerak Sendi Pada Penderita Diabetes Mellitus Tak Tergantung Insulin (dmtti) 1996/4
- Mutasi Dna Mitokondria Dan Diabetes Melitus 2003/22
- Low Hdl Cholesterol And Fibrinogen Level Associates With Coronary Heart Disease In Patients With Metabolic Syndrome 2012/7
- Hubungan Komponen Sindroma Metabolik Dan Kadar Testosteron Pada Penderita Dmt2 Mets 2012/4
- Association Of Plasma Viscosity And Fibrinogen Concentration With Blood Pressure In T2dm Mets 2009/1
- Association Of Lipoprotein (a) With Hypertension In T2dm Mets 2009/1
- Nutritional Status Of Student Candidates In Airlangga University 2009/1
- Apolipoprotein-b, Blood Viscocity And Plasma Viscocity In Type 2 Diabetes Mellitus-metabolic Syndrome 2009/1
- Association Between Metabolic Syndrome Component And Microalbuminuria In Type 2 Diabetes Mellitus Metabolic Syndrome 2009/1
- Association Between Metabolic Syndrome Components With Ldl3 And Apo B In T2dm Obese 2009/1
- Frequency Of Cardio Metabolic Risk Components In T2dm Mets 2009/1
- Association Between Metabolic Syndrome Components And Adiponectin Levels In T2dm Mets 2009/1
- Microalbuminuria In Patients With T2dm And Non Dm 2005/1
- The Metabolic Syndrome In Patients With Mitochondrial Diabetes Mellitus 2005/21
- Association Of Acute Ischaemic Stroke In Type 2 Diabetes Mellitus (t2dm) With Arterial Stiffness 2005/1
- Patients Older Than Fifty Years Old With Type X3 Dm (totally Insulin Dependent Dm Derived From T2dm) 2005/1
- Management Of Pregnant Patient With Type 1 Diabetes Mellitus And Its Complication 2005/1
- Insulin Resistance Pattern In Newly Diagnosed T2dm Based On Homa R And Homa B 2005/1
- Correlation Between Insulin Resistance And Small Dense Ldl Inpatients With T2dm (cross Sectional Descriptive Study In Surabaya) 2005/1
- Nephrogenic Diabetes Insipidus Due To Glibenclamide (application Of Formula 4- 3- 2- 1) 2005/1
- A Patient Diabetic Ketoacidosis With Acute Inferior And Right Ventricle Myocard Infarction. (application Formula N 1 And N X 2) 2005/1
- Comparative Value Of The Metabolic Syndrome According To Who 1998, Ncep-atp-iii 2001, And Idf 2005 Criteria In Civil Servant At Surabaya 2006/6
- The Prevalence Of Small Dense Ldl In Normal Lipid Profile Patients With T2dm Mets 2006/1
- Fibrinogen Level In Patients With T2dm Mets 2006/1
- Elevated Apo B, Low Hdl In Patients With T2dm Mets (cross Sectional Descriptive Study In Surabaya) 2006/1
- Presence Small Dense Ldl In The Normal Ldl C And Tg In Patients With T2dm Mets (cross Sectional Descriptive Study In Surabaya) 2006/1
- Uric Acid Level In Patients With T2dm Mets A Cross Sectional Study In Surabaya 2006/1
- The Prevalence Of Hypertension In Patients T2dm Mets A Cross Sectional Study In Surabaya 2006/1
- Correlation Of Adiponectin With Microalbuminuria In T2dm Mets Patients 2011/3
- Association Of Fibrinogen Concentration, Plasma Viscosity, And Blood Viscosity With Insulin Resistance In Type 2 Dm Mets 2011/14
- Component Profile In The Metabolic Syndrome Of Diabetic Patients Received Fixed Dose Combination Of Glibenclamide And Metformine Before And After Treatment 2011/5
- Correlation Between Lipoprotein(a) With Estradiol Level In Type 2 Diabetes Mellitus 2011/1
- Association Of Tsh And Uric Acid Level In Patient With Hyperthyroid 2010/1
- Association Between Erythrocyte Transketolase And Svcam 1 In T2dm 2010/1
- Association Of Adiponectin With Microalbuminuria In Patients With T2dm Mets 2010/1
- A Patient With Isolated Acth Syndrome And Diabetes Mellitus: A Case Report 2010/1
- Association Of Adiponectin With Insulin Resistance, High Density Lipoprotein Cholesterol In Patients With T2dm Mets 2010/1
- Correlation Of Erythrocyte Transketolase And Hs Crp In Patient With T2dm 2010/1
- Association Between Uric Acid And Insulin Resistance In T2dm Patient With Mets 2010/1
- Association Between Uric Acid And Adiponectin Levels In Patient With T2dm Mets 2010/1
- Profile Of Plasma Fibrinogen Level In Diabetic Patient Received Glibenciamide Metformin Fixed Dose Combination Therapy 2010/1
- Testosteron Level In Insulin Resistance Among T2dm Patients 2010/1
- Metabolic Syndrome Components And Prostate Specific Antigen In T2dm 2010/1
- Association Of Lipid Profile With Microalbuminuria In T2dm Mets Patients (the Role Of Total Cholesterol And Ldl Cholesterol Levels) 2010/1
- Association Of Serum Uric Acid Level And Microalbuminuria In T2dm Mets Patients 2010/1
- Biochemical Markers Of Liver Are Not Influenced By Thyroid Function In Patients With Hyperthyroid 2010/1
- Correlation Of Thyroid Biochemical Markers And Body Mass Index In Patients With Hyperthyroid 2010/1
- Psa Level Is Correlate With Insulin Resistance In T2dm With Mets 2010/1
- Testosterone Levels And Waist Circumferences In T213m With Mets 2010/1
- Association Of Body Mass Index With The Levels Of Psa Among Type 2 Diabetes Mellitus 2010/1
- Type X Dm As Observed In Surabaya By 1991 : Are There Differences With Lada (1993)? 2010/1
- Serum Uric Acid Level In Patients With Type 2 Diabetes Mellitus And Metabolic Syndrome 2007/1
- Antioxiclant Status In Controlled And Uncontrolled Type 2 Diabetes Mellitus With Metabolic Syndrome 2007/1
- Association Of Serum Lipid, Lipoprotein A, And Inflammatory Biomarker With Renal Function In Type 2 Diabetes Mellitus 2007/1
- Asosiasi Prediktif Antara Sindroma Metabolik Dengan Kekakuan Arteri Pada Penderita Diabetes Mellitus Tipe 2 2008/8
- Efek Glimepiride Terhadap Kadar Adiponektin-hmw Dan Kekakuan Vaskuler Pada Diabetes Mellitus - Metabolic Syndrome 2009/9
- Profil Kadar Asymmetric Dimethylarginine (adma) Pada Diabetes Mellitus Tipe 2 Dengan Sindroma Metabolik 2008/5
- Cinula®: The Fdc Of Cinnulin Pf-250mg, Ala-300mg, And Vit. B12-100mcg 2010/14
- Enercore®: The Novel Fdc Of D-ribose, L-carnitine, Coq10, And Mg++ 2010/8
- Association Of Lipoprotein (a) With Hypertension In T2dm-mets 2009/1
- Korelasi Antara Kadar Aic Dengan Derajat Retinopati Pada Penderita Diabetes Melitus Tipe Ii (studi Di Instalasi Rawat Jalan Mata Rsud Dr. Soetomo Surabaya & Rs Mata Undaan) 2010/6
- Biochemical Profile Of A1c, Homa-ir, Homa-b And Insulin Level In T2dm-mets And Its Relationship 2009/1
- Association Of Lipoprotein (a) With Hypertension In T2dm-mets 2009/1
- Correlation Of Ldl-3 With Insulin Resistance In Type-2 Diabetes Mellitus Patient 2011/2
- Correlation Between Glycemic Control And Microalbuminuria In T2dm Patients 2011/2
- Correlation Between Adiponectin And A1c In T2dm Patients 2011/7
- Correlation Of Adiponectine Level And Insulin Resistance 2011/7
- The Effect Of Low Impact Aerobic Exercise In Increased Functional Balance In Patients With Type 2 Diabetes Mellitus 2007/1
- Comparison Distal Latency Sympathetic Skin Response In Type 2 Diabetic Patients Pre And Post Low Impact Aerobic Exercise 2007/1
- The Comparison On Suralis Nerve Conduction Study Before And After Low Impact Aerobic Exercise In Type 2 Diabetic Patients 2007/10
- The Association Of Acute Ischaemic Stroke In Type 2 Diabetes Mellitus With Arterial Stiffness 2007/1
- The Association Of Arterial Stiffness With Metabolic Syndrome In Type 2 Diabetes Mellitus 2007/1
- Asymmetric Dimethylarginine Blood Level On Diabetic Kidney Disease Before And After Haemodialysis With Intravenous N‐acetylcysteine 2007/1
- The Influence Of Intravenous N‐acetylcysteine In Reducing Pulse Pressure In Patients With Diabetic Kidney Disease Before And After Hemodialysis 2007/1
- Proportion Of Elevated Apolipoprotein‐b Level With Normal Low Density Lipoprotein‐ Cholesterol In Patients With Type‐2 Diabetes Mellitus 2007/1
- Lipoprotein (a) Level In Type 2 Diabetes Mellitus‐metabolic Syndrome And Type 2 Diabetes ‐ Non Metabolic Syndrome Patients 2007/1
- Apolipoprotein‐b Level And Cardiovascular Risk Factors In Government Employees In Surabaya‐indonesia 2007/1
- Small Dense Ldl And Metabolic Syndrome In Type‐2 Diabetes Mellitus 2007/1
- Nutritional Pattern Of Patients With The Metabolic Syndrome As Observed In Surabaya 2007/1
- Adiponektin And Serum Creatinine Level In Patients With Type 2 Diabetes Mellitus 2007/1
- Adiponektin And Insulin Resistance In Patients With Type 2 Diabetes Mellitus 2007/1
- Adiponectin And Cardiovascular Complications In Type 2 Diabetic Patients 2007/1
- Lipid Profile In Newly Diagnosed Type 2 Dm In Relation With Glycaemic Control 2007/10
- Microalbuminuria In Patients With T2dm And Non‐dm 2007/1
- Correlation Between Insulin Resistance And Small Dense Ldl Among Government Employees 2007/1
- Elevated Of Small Dense Ldl With Normal Ldl‐cholesterol In Type‐2 Diabetes Mellitus 2007/1
- Association Of Diabetic Neuropathy With Brachial Ankle Pulse Wave Velocity In Patients 2007/1
- Profile Of Plasma Fibrinogen Level In Diabetic Patient Received Glibenclamide-metformin Fixed Dose Combination Therapy 2010/1
- Psa Level Is Correlate With Insulin Resistance In T2dm With Mets 2010/1
- Association Of Lipoprotein (a) Level And Coronary Heart Disease 2011/7
- Correlation Between Fibrinogen, Blood And Plasma Viscosity With Glycemic Control In Patients With Type 2 Diabetes Mellitus 2011/8
- Association Of Adiponectin With Insulin Resistance, High-density Lipoprotein Cholesterol In Patients With T2dm-mets 2010/1
- Association Between Uric Acid And Insulin Resistance In T2dm Patient With Mets 2010/1
- Biochemical Markers Of Liver Are Not Influenced By Thyroid Function In Patients With Hyperthyroid 2010/1
- Correlation Of Thyroid Biochemical Markers And Body Mass Index In Patients With Hyperthyroid 2010/1
- Association Of Serum Uric Acid Level And Microalbuminuria In Patients With T2dm-mets 2010/1
- Association Of Lipid Profile And Microalbuminuria In Patients With T2dm-mets (the Role Of Total Cholesterol And Ldl Cholesterol) 2010/1
- Association Between Plasma Fibrinogen Levels And Total Body Fat In Government Emplooyees 2007/1
- Nutritional Status Of Student Candidates In Airlangga University 2009/8
- Metabolic Syndrome As Observed In Surabaya 2005/3
- Korelasi Komponen Sindroma Metabolik Dengan Ldl3 Dan Apo B Pada Pasien Diabetes Gemuk 2009/3
- Association Of Triglycerides/hdl-cohlesterol And Insulin Resistance In T2dm- Mets 2011/1
- Hubungan Antara Komponen Sindroma Metabolik Dengan Kadar Adiponektin Pada Penderita Diabetes Mellitus Tipe 2 2009/4
- Correlation Between Adiponectin And Insulin Resistance With Glycernic Control In Patient With T2dm Mets 2011/1
- Testosterone Levels And Adiponectin In T2dm With Mets 2011/1
- Correlation Between Lp(a) With Microalbuminuria In Type 2 Diabetes Mellitus 2011/1
- Association Of Testosteron Level And Lipid Profile In Patient With T2dm-mets 2011/1
- Hubungan Antara Komponen Sindroma Metabolik Dengan Albuminuria Pada Penderita Diabetes Mellitus Tipe 2 Dengan Sindroma Metabolik 2009/5
- Metabolic Syndrome Components Profile In Diabetic Patients With Symptomatic Knee Osteoarthritis 2011/1
- The Role Of Metabolic Syndrome Components Profile In Diabetic Patients With Symptomatic Knee Osteoarthritis 2011/1
- Correlation Between Serum Estradiol And Lipid Profile In Patient With Type 2 Diabetes Mellitus 2011/1
- Correlation Between Apob With Microalbuminuria In Patient With Type 2 Diabetes Mellitus 2011/1
- Radiographic Findings Of Diabetic Patient With Symptomatic Knee Osteoarthritis Based On Diabetes Duration 2011/1
- Lipid Profile [lp(a), Apob, Sldl And Other Conventional Lipids] Of Patients With Type-2 Diabetes Mellitus 2011/1
- Kadar Transketolase Berkorelasi Negatif Dengan Marker Inflamasi Pada Penderita Diabetes Mellitus Tipe 2 2010/5
- Hubungan Antara Kadar Transketolase Eritrosit Dengan Svcam-1 Pada T2dm 2010/7
- Kadar Testosteron Dan Lingkaran Pinggang Pada Penderita Dm Tipe 2 Dengan Sindroma Metabolik 2011/4
- The Influence Of Intravenous N-acetylcysteine In Reducing Pulse Pressure In Patients With Diabetic Kidney Disease Before And After Hemodialysis 2007/0
- Efek Glimepiride Terhadap Kadar Asymmetric Dimethylarginine (adma) Dan Kekakuan Vaskular Pada Diabetes Mellitus Tipe-2 2008/0
- The Diabcare Asia 2008 Study – Outcomes On Control And Complications Of Type 2 Diabetic Patients In Indonesia 2010/10
- Asymmetric Dimethylarginine Blood Level On Diabetic Kidney Disease Before And After Haemodialysis With Lntravenous N-acetylcysteine 2007/0
Pengabdian Kepada Masyarakat
- New Insights Into The Management Of T2dm With The Novel Insulin Sensitizer (its Seven Possible Molecular Pathogenetic Mechanisms) 2012/
- The Usage Of Several Surabaya-formulas In Daily Clinical Practice (clinical Experiences With Aspart, Detemir, And Biphasic Insulin Aspart) 2012/
- Garis Besar Pola Makan Dan Pola Hidup Sebagai Terapi-dasar Penderita Diabetes Mellitus 2012/
- The Roles Of Micronutrients And Vitamins In The Management Of Diabetes Mellitus 2012/
- Selecting Glp-1 Analogues : Focus On Glp-1 Receptor Agonist (making An Entry Into Recent Update In The Management Of Diabetes) 2012/
- Clinical Experiences With Insulin Glargine & Glulisine, And Glimepiride-m (surabaya – Practical Formulas Esp. For Diabetic-outpatients, And Introduction With The Origin Study) 2012/
- The New Management Of Insulin Resistance In Patients With T2dm (the Roles Of Inlacin®, A Novel Insulin Sensitizer) 2012/
- An Update In The Management Of Diabetes With Glp-1 (the Roles Of The First Human Glp-1 Receptor Agonist) 2012/
- Surabaya-practical Insulin Formulas Esp. For Diabetic-outpatients (clinical Experiences With Lantus®, Amaryl-m®, And Apidra®) 2012/
- Docklink Update : Capita Selecta 2010-2012 (clinical Experiences Included) 2012/
- The Benefits Of Vit. B1, B6, B9, And B12 In Patients With T2dm (from Applied Basics To Possible Clinical Application) 2012/
- The Rationale Combination Of Glimepiride And Metformin (its Possible Add-on Therapy With Glargine Insulin) 2012/
- The Use Of Insulin In Daily Clinical Practice (novorapid®, Novomix®, And Levemir® : In Formulas Especially For Diabetic Outpatients) 2012/
- Optimal Two Oads And/or Insulin Combination In The Treatment Of T2dm (focus On Glimepiride, Metformin, And Glargine Based On Clinical Experiences) 2012/
- Surabaya-practical Insulin Formulas For Diabetic-outpatients (the Rationale Use Of Novorapid®, Novomix®, Levemir® In Daily Practice) 2012/
- Diabetes Mellitus : Kapita Selekta 2001-a 2001/
- Diabetes Mellitus : Capita Selecta – 2000 2001/
- Recent Advances In The Treatment Of Osteoporosis 2001/
- Diabetes Mellitus – Capita Selecta 2001-c 2001/
- The Roles Of Naftidrofuryl On Peripheral Occlusive Arterial Disease 2001/
- Ldl And Hdl: “villain” And “hero” In Atherogenesis 2001/
- Diabetes Mellitus: Capita Selecta 2001-b 2001/
- Recent Advances In Diabetic Nephropathy 2001/
- Poad: An Important Marker Of Systemic Atherosclerosis 2001/
- Diabetes Mellitus: Capita Selecta 2001-d 2001/
- Oxidative Stress In Diabetes Mellitus: An Update 2001/
- Diabetes And Cvd: Double Jeopardy 2001/
- Parenteral Nutrition In Patients With Diabetes Mellitus 2001/
- Obesity: Health Or Disease 2001/
- Diabetes Mellitus And Infection 2001/
- Diabetes Mellitus Tipe 3c 2001/
- Diabetes Mellitus 2001/
- Adrenal : Patogenesis, Diagnosis, Dan Terapi 2001/
- Diabetes Update 2001-a 2001/
- Experiences On Pen In Patients With Diabetes Mellitus 2002/
- Diabetes Mellitus: Capita Selecta – 2002 B 2002/
- Diabetes Mellitus – 2002 2002/
- Informasi 13 Macam Diet – Diabetes Rsud Dr. Soetomo Surabaya 2002/
- Diabetes And Cvd: Double Jeopardy 2002/
- Pleiotropic Effects Of Statin: Beyond Lipid Lowering 2002/
- The 3rd Gen. Sulphonylurea With Specific Properties 2002/
- Pleiotropic Properties Of Statins 2002/
- Diabetes Mellitus In Older Persons 2002/
- Obesity And Insulin Resistance 2002/
- Obesity – Capita Selecta - 2002 2002/
- Rationale Treatment Of Hypertension In Diabetes Mellitus 2002/
- Obesity And Diabetes Mellitus 2002/
- Diabetic Nephropathy: Present And Future 2002/
- Drug Therapy For Peripheral Occlusive Arterial Disease 2002/
- Diabetes Mellitus And Cardiovascular Diseases 2002/
- A Novel Su With Pleiotropic Properties 2002/
- Is Obesity A National Epidemic In Indonesia ? 2002/
- Enteral Nutrition In Practice For Patients With Diabetes Mellitus 2003/
- Recent Advances In The Prevention And Treatment Of Osteoporosis 2003/
- Peca-gomes: Pleiotropic Effects Of Statins 2003/
- Advances In Diabetes Treatment Options 2003/
- Metabolic Syndrome: Obesity Is The Central Problem 2003/
- Atherothrombosis: An Event In All Vascular Beds 2003/
- The Cumulative Metabolic Syndrome 2003/
- Combined Therapy Of Oral Agent And Insulin 2003/
- New Approach In The Treatment Of T2dm And Metabolic Syndrome 2003/
- Atherosclerosis: Brain And Dm In The Elderly 2003/
- Management Of Sirs-sepsis On Patients With Diabetes Mellitus 2003/
- The Roles Of Micronutrients In The Treatment Of Diabetes Mellitus 2003/
- A Therapeutic Option In The Treatment Of Pre-dm, Igt, And T2dm 2003/
- Map Of Fat Cell In Obesity 2003/
- Diabetes Update 2003 –a 2003/
- Glargine: A Novel Long - Acting Peakless Insulin Analogue 2003/
- The Effective And Safe Drug In The Treatment Of Poad 2003/
- Gabapentin In Painful Diabetic Neuropathy 2003/
- Obesity: Capita Selecta 2003 2003/
- Perencanaan Makan Bagi Penderita Diabetes Mellitus 2003/
- Selecting The Appropriate Hypoglycemic Agent 2003/
- Pleiotropic Roles Of Ace-i In Patients With Diabetes Mellitus 2003/
- Basic Principles Of Parenteral Nutrition For Diabetic Patients 2003/
- Visceral Fat As The Culprit Of The Metabolic Syndrome 2003/
- Diabetes Mellitus And Periodontal Disorders 2003/
- Metabolic Syndrome A Cluster Of 10 Possible Compounds Of Metabolic And Cv Risk Factors 2003/
- Diabetes Mellitus: Capita Selecta – 2003a 2003/
- Diabetes Mellitus: Capita Selecta – 2003b 2003/
- Hdl-cholesterol: The Missing Link In Cv Risk Reduction 2003/
- Mufa Sangat Bermanfaat Bagi Penderita Diabetes 2003/
- Hidup Sehat Bersama Diabetes 2003/
- Pleiotropic Roles Of Ace-i In Patients With Diabetes Mellitus 2003/
- Current Strategies For Prevention And Treatment Of Poad 2004/
- Atherothrombosis, An Event In All Vascular Beds 2004/
- Metabolic Syndrome - Insulin Resistance Syndrome 2004/
- Metabolic Syndrome Vs Insulin Resistance Syndrome 2004/
- New Insights Into Oral Agents In The Treatment Of T2dm 2004/
- New Strategy For The Treatment Of T2dm 2004/
- Diabetes Update – 2004 2004/
- Insulin Glargine Combined With Oral Agent In T2dm 2004/
- Preventive And Therapeutic Strategies For Osteoporosis 2004/
- Painful Diabetic Neuropathy: Patogenesis And Treatment 2004/
- Current Strategies For The Treatment Of T2dm 2004/
- Current Strategies For Prevention And Treatment Of Poad 2004/
- Pleiotropic Effects Of Orlistat In Obesity 2004/
- Pleiotropic Effects Of Metformin On The Metabolic Syndrome 2004/
- A Novel Fixed-dose Oral Agent For T2dm: Metabolic-cardiovascular Care 2004/
- Clinical Strategies “dalang” For The Treatment Of Pdn 2004/
- Practical Strategies (dh-alcoan) For The Treatment Of Diabetic Nephropathy 2004/
- A Breakthrough In The Metabolic-cardiovascular Care In T2dm 2004/
- Diabetes Mellitus: Capita Selecta-2004 2004/
- The Metabolic – Cardiovascular Syndrome In T2dm 2004/
- Statin: Pleiotropic Effects Beyond Cholesterol Lowering 2004/
- Glargine: A Novel Long Acting Peakless Insulin Analogue 2004/
- Current Strategies For The Metabolic-cardiovascular Care In T2dm 2004/
- Diabetes Update – 2004 2004/
- Ctoi In T2dm: Indications And Therapeutic Regimens 2004/
- Alpha Lipoic Acid And Diabetes Mellitus 2004/
- Key Player Of The Widened Metabolic – Cardiovascular Syndrome 2004/
- Rationale Combined Therapy With Cardiovascular Properties 2004/
- Rationale Strategy For The Metabolic – Cardiovascular Care In T2dm T2dm 2004/
- Pleiotropic Effects Of Metformin In The Metabolic Syndrome 2004/
- The Mets: One Of The Major Threat To Human Health 2005/
- Bridging The Gap In The Lipid Management 2005/
- The Core Of The Metabolic Syndrome 2005/
- Clinical Variety Of Ctoi In Daily Practice 2008/
- Metabolic – Cardioprotective Effects Of A Novel Oad 2005/
- Glimepiride: A Novel Metabolic – Cardioprotective Oad 2005/
- Recent Advances In Diabetes Mellitus: 2002-2005 2005/
- Thyroid Storm: A Life-threatening Thyrotoxicosis 2005/
- Workshop On Diagnosis And Treatment Modalities Of Thyroid Disease 2005/
- Gliclazide: A Specific Oad With Metabolic-cardioprotective Properties 2005/
- Hdl – C And Diabetes: A Clinical Target For Intervention 2005/
- Erectile Dysfunction In Patients With Diabetes Mellitus 2005/
- Adipose Tissue: A New Target For Cardiovascular Disease 2005/
- Raising Hdl – Cholesterol, The New Target? 2005/
- Subcutaneous Insulin Degradation Syndrome 2005/
- A Novel Oad With Metabolic – Cardioprotective Properties 2005/
- Metformin Is More Than An Oral Antihyperglycemic Drug 2005/
- Once-daily Therapeutic Regimen With Linagliptin For T2dm 2012/
- Metabolic Syndrome: From Obesity To Clinical Relevances 2005/
- Targeting Hdl – C In Lipid Management 2005/
- Micro – And Macroalbuminuria In Diabetic Nephropathy 2005/
- Treatment Of Painful Diabetic Neuropathy 2005/
- Basic Mechanism Of Painful Diabetic Neuropathy 2005/
- Thyroid Storm: A Life-threatening Thyrotoxicosis 2005/
- Dyslipidemia And Diabetes Mellitus 2005/
- Low Hdl – C: The Missing Link Beyond Ldl–c Lowering 2005/
- Diabetes Update – 2005 2005/
- Low Hdl – C And Cv Risk Factors In T2dm 2005/
- Insulin Resistance And Cv Risk Factors In T2dm 2005/
- Rimonabant: A Cannabinoid Type-1 (cb1) Receptor Blocker 2005/
- The Future Of Drug Treatment In Obesity 2005/
- Niaspantm, A Broad Spectrum Lipid Drug With Powerful Hdl-c Raiser 2005/
- Pengelolaan Resistensi Insulin Dan Penyakit Terkait 2005/
- Insulin Usages In Hospital And Clinical Daily Practice 2005/
- Osteoporosis: Capita Selecta – 2005 2005/
- A Novel Drug For Ir-pre Dm-mets-t2dm And Cvd 2005/
- Pengelolaan Resistensi Insulin Dan Penyakit Terkait 2005/
- Obesity An Overview: Epidemiology, Pathogenic Mechanism And Treatment 2005/
- The Metabolic Syndrome As Observed In Surabaya-indonesia 2006/
- Gliclazide-mr: “sepi-mecar”effects Beyond Glucose Lowering 2006/
- A Novel “two-in-one” Drug Fixed Combination Of Ros And Met 2006/
- New Insights Into The Management Of Pts With Atherothrombosis 2006/
- Clinical Experiences With Glargine In Daily Practice 2006/
- Hypertension And Diabetes In Diabetic Nephropathy 2006/
- Thyroid Eye Disease: Pathogenesis And Treatment 2006/
- Thyroid Storm: Pathogenesis And Treatment 2006/
- Drug Therapy For Obesity: An Update 2006/
- Several Oads With Mecar Properties 2006/
- Ppn : Peripheral Parenteral Nutrition 2006/
- Therapeutic Guidelines (“dha – Licoar” ) For Diabetic Nephropathy 2006/
- Pathogenesis And Management Of Painful Diabetic Neuropathy 2006/
- “sepi-mecar” Effects: Recent Findings In The Treatment With Sulpfonylurea 2006/
- Diabetes And Infection 2004/
- Niacin-pr: A Novel Major Driver In Cv Care 2006/
- A Novel “two In One” Drug With Mecar Properties 2006/
- Capita Selecta In Endocrinology-2006 2006/
- Pleiotropic Properties Of Statin Beyond Lipid Lowering 2006/
- Bridging The Gap In The Lipid Management 2006/
- Strategy For Treatment Of Low Hdl – C 2006/
- Diabetic Nephropathy: From Basic To Clinics 2006/
- Diabetes Update - 2006 2006/
- New Prolonged-release Metformin With Mecar Benefits 2006/
- Penyakit Kelenjar Adrenal 2007/
- Hypertension In Diabetic Nephropathy 2006/
- Clopidogrel And Atherothrombosis, The “real-world” In Patients With T2dm 2006/
- Glimepiride: An Oad With Mecar Properties 2006/
- Graves’ Disease And Thyroid Storm 2006/
- Update On The Management Of Peripheral Arterial Disease 2006/
- Par Enteral Nutrition In Internal Medicine 2006/
- The Metabolic Syndrome: Prevention And Treatment Of Its Cmr 2006/
- From Obesity And Metabolic Syndrome To Diabetes And Cardiovascular Diseases 2006/
- Overview Of Diabetes, Obesity And Metabolism 2007/
- Surabaya-practical Insulin Formulas For Diabetic-outpatients 2012/
- Therapeutic Update In The Management Of T2dm With Glp-1 Analogue 2012/
- Management Of T2dm: Should Metformin Be At The Core Of Treatment 2007/
- The Metabolic Syndrome : Capita Selecta - 2007 2007/
- Pancreatic -cell Dysfunction : The Cardinal Cause Of T2dm 2007/
- Pleiotropic Properties Of Cilostazol On Vascular Events 2007/
- Ubiquinone (coq10) : Several Possible Benefits For Patients With Diabetes Mellitus 2007/
- New Insights Into The Management Of Diabetic Neuropathy 2007/
- Management Of T2dm With Glimepiride: Beyond Glucose Control 2007/
- Paha-oxidative Stress And Vascular Complications 2007/
- Thyroid Storm: Diagnosis And Management 2007/
- Fixed Dose Combination Of Glibenclamide-metformin 2007/
- The Obesity Pandemic: The “time-bomb Disease” In The Future? 2007/
- Basic Principles Of Parenteral Nutrition In Clinics 2007/
- Capita Selecta In Endocrinology And Metabolism - 2007 2007/
- Dhl-oir: The Major Focus Of Therapy Ada/easd – 2006 2007/
- Novel Fixed Dose Combination Of Glimepiride / Metformin 2007/
- Oxidative Stress And Its Clinical Relevancies 2007/
- Cilostazol: Properties And Benefits On Vascular Events 2007/
- The Metabolic Syndrome (lrd Stage-3): Preclinical Stage Of The Cvds 2007/
- Cardiometabolic Risk Factors In Patients With Diabetes 2007/
- Rationale Fixed Dose Combination : Glibenclamide-metformin 2007/
- Capita Selecta On Metabolic Cardiovascular Disease–2007 2007/
- Update Treatment Of T2dm With Insulin Sensitizer 2007/
- Fdc Of Glibenclamide – Metformin In Daily Practice 2007/
- Varenicline (champix®) : A Breakthrough For Smoking Cessation Treatment 2007/
- Diabetes Mellitus 2007/
- The Roles Of Formula -1 And X12 In Hyperglycemic Crisis 2007/
- Graves’ Disease And Thyroid Storm: Classical And Non-classical 2007/
- Astaxanthin – Oxidative Stress – Diabetes Mellitus 2007/
- Apidra® (insulin Glulisine): A Novel Rapid-acting Insulin Analogue 2008/
- Pleiotropic Properties Of Pletaal® And Its Benefits On Vascular Events 2008/
- Cardioprotective Properties Of Metformin Treatment 2008/
- Treatment Updates For Diabetic Dental Patient 2008/
- Cilostazol : A Broad Specrtrum Antithrombotic Drug 2008/
- Basic Principles Of Pen And Maintenance Fluid Therapy 2008/
- The Metabolic Syndrome In The Elderly 2008/
- Amaryl-m®: The Novel Fdc Of Glimepiride And Metformin 2008/
- Bonviva® : The Novel Therapeutic Drug For Osteoporosis 2008/
- Astaxanthin : The Novel Powerful Antioxidant 2008/
- New Insights Into Cardiovascular Protection In Pts With T2dm 2008/
- The Metabolic Syndrome: Capita Selecta-2008 2008/
- Cardiovascular Benefits Of Metformin For Pts With T2dm 2008/
- Thetrend In Emerging Lifestyle-related Diseases In Indonesia 2008/
- Maintenance Fluid Therapy In Pts With Diabetes Mellitus 2008/
- Mitochondrial Dysfunction And Oxidative Stress In T2dm 2008/
- The Ideal High-tech Fdc Of Glibenclamide And Metformin 2008/
- Practical Guidelines Of Insulin Analoguein Clinical Practice 2008/
- Capita Selecta In Endocrinology And Metabolism - 2008 2008/
- The High-tech Fdc Of Metformin And Glibenclamide (improving 2 Main Defects Of T2dm And Showing 31 Cardiometabolic Properties) 2008/
- Statin Evidence: Its Pleiotropic Properties For Cv Protection (partly Indicated As Peca-gomesaa – For Patients With Diabetes Mellitus) 2008/
- The Potential Roles Of B-vitamins In Diabetic Complications (emerging Multiple Benefits For Patients With Diabetes Mellitus) 2008/
- The Roles Of Acarbose In The Elderly With Mets 2008/
- Thyroid Eye Disease: From Basic To Clinics (the Roles Of Thyrozol®, And Steroid Therapy With Formulas 7.1.5) 2008/
- Thyroid Storm: Quick Diagnosis And Quick Treatment (the Roles Of Formulas G/o – P-39.5 – 120 And Cs-7.1.5) 2008/
- Astaxanthin : The Novel Powerful Antioxidant With Clinical Benefits 2008/
- Cardiovascular Aspect Of Diabetes Mellitus (from Basics To Clinical Relevancies) 2008/
- Smbg: Related Theory And Recommended Practice With Surabaya-experiences 2008/
- Therapeutic Possibilities Of B-vitamins For Diabetic Complications 2008/
- A Novel Strategy For The Treatment Of Diabetes Mellitus 2008/
- Hypertension And Diabetes: The Deadly Conspiration 2008/
- Astaxanthin : The Novel Powerful Antioxidant With Multiple Benefits 2008/
- Emerging Multiple Properties Of High Dose Thiamine And B6-b12 Vitamins 2008/
- A Novel Oad With Broadspeactrum Therapeutic Value For Pts With T2dm 2008/
- The 22 Pleiotropic Properties Of Statin And Cardiovascular Diseases 2008/
- Konsensus Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia 2011 2011/
- Clinical Experiences With Glargine In Daily Practice (formulas: 1/3, Step Up, Step Down Methods: A, B And C) 2006/
- Konsensus Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia 2006 2006/
- Clinical Benefits Of Fdc Microelements (diasulin®) For Pts With Dm 2008/
- The Metabolic Syndrome: A Lifestyle Related Disease 2009/
- The Therapeutic Values Of Rosiglitazone In Pts With T2dm 2009/
- Ppeccat-gommesaab : The 16 Of 22 Pleiotropic Properties Of Atorvastatin 2009/
- Long (lantus®) And Rapid (apidra®) Acting Insulin Analogues In Daily Practice 2009/
- Insulin: Biosintesis, Macam, Dan Indikasi Klinik 1988/
- Multiple Indications And Its Clinical Benefits Of Sitagliptin 2009/
- The Metabolic Syndrome: From Obesity – The Mets & Cmr – To The Cmds 2009/
- The Obesity Risks: The Mets And Cmr As A Couple Of Preclinical Disease 2009/
- Emerging Therapeutic Values Of High Dose Thiamine, And B6, B12 Vitamins 2009/
- The Novel Powerful Antioxidant With Multiple Possible Clinical Benefits 2009/
- The Cinula®: A Novel Fdc Of Cinnulin Pf, Ala, And Vit B12 2009/
- Cardioprotective Roles Of Rosiglitazone In Patients With T2dm 2009/
- A Memorial Review Article For The 15-year Clinical Experiences With Metformin 2009/
- Sitagliptin: The Novel Oad With Dual Effects On Pancreatic And Cells 2009/
- Pioglitazone Is More Than An Insulin Sensitizer 2009/
- The Mets And Cmr: The “time Bomb Preclinical Diseases” By The Year 2020 2009/
- The Cinula®: The Fdc Of Cinnulin Pf, Ala, And Vit B12 2009/
- Glucovance®: The Hi-tech Fdc Of Metformin And Glibenclamide 2009/
- Comprehensive Therapy Of Osteoporosis 2009/
- Hyperglycemic Crises (dka And Hhs) In Adult Patients With Diabetes 2009/
- Breakthrough On Diagnosis And Treatment In Endocrinology 2009/
- The Hi-tech Fdc Of Metformin And Glibenclamide 2009/
- The Cinula® Is More Than Rationale Therapy In Diabetic Polyneuropathy 2009/
- Trajenta (linagliptin), A Unique Dpp4-inhibitor For The Management Of T2dm 2012/
- The New Emerging Therapeutic Values Of High-dose Thiamine 2009/
- The Coq10-com : The Novel Fdc Of Coq10, L-carnitine And Ala (its Metabolic And Cardiovascular Properties For Patients With Dm) 2012/
- Pmh With Its Increased Cardiovascular Risks In Diabetes (the Roles Of Dexanorm® Based On The Idf Guideline 2007) 2012/
- Liraglutide (victoza®), The First Human Glp-1 Analogue For The Treatment Of T2dm (its Roles In The Improvements In Lipid Profile And Cv Biomarkers) 2012/
- Clinical Formulas With Apidra® And Lantus® For Diabetic Outpatients (the Use Of Formulas X2, 3.3.5, 2.1, Etc In Daily Practice) 2012/
- Postprandial Hyperglicemia In The Progression Of Atherosclerosis (therapeutic Benefits Of Dexanorm® Based On Idf Guideline 2007) 2012/
- Inlacin®, The Novel Insulin Sensitizer In Clinical Practice (its Roles On Mono–and Add–on Therapy For Patients With Diabetes) 2012/
- Recent Advances In The Diagnosis And Management Of Diabetic Neuropathy (introducing: Duloxetine) 2009/
- Clinical Daily Practice With Long (lantus®) And Rapid (apidra®) Insulin Analogues 2009/
- “paham”: The Bridge To Diabetic Vascular Complications 2009/
- The Fdc - Cinula® With Multiple Clinical Benefits 2009/
- Lantus® (insulin Glargine): Some Information Revealing The Truth 2009/
- Lantus® Efficacy And Safety Profile Favor Consensus Ada/easd-2009 2009/
- Enercore®: The Fdc Of D-ribose, L-carnitine, Coq10, And Mg++ 2009/
- Triple Properties Of Cinula® With Multiple Therapeutic Values 2009/
- Selected Oads: Glucovance®, Galvus®, Januvia®, And Cinula® 2009/
- Januvia®: A Novel Oad (dpp-4i) With Triple Properties 2009/
- Comprehensive Therapy Of Osteoporosis 2009/
- Capita Selecta In Diabetes Mellitus – 2009 2009/
- Asthin Force®: The Novel Powerful Antioxidant In Clinical Use 2009/
- Coq10-com: The Novel Fdc Of Coq10, L-carnitine, And Ala 2009/
- Asthin Force®: The Novel Powerful Antioxidant In Clinical Usage 2009/
- Glucobion®: The Balanced Fdc Of 7 Vitamins And 4 Minerals 2010/
- Enercore®: The Novel Fdc Of D-ribose, L-carnitine, Coq10, And Mg++ 2010/
- Cinula®: The Fdc Of Cinnulin Pf-250mg, Ala-300mg, And Vit. B12-100mcg 2010/
- Garis Besar Diet Oral – Enteral, Dan Par Enteral Pada Diabetes 2010/
- The New Emerging Lifestyle In Indonesia And Its Consequences 2010/
- Five Minute-quick Diagnosis Of Thyroid Crisis With G/o.p.39,5.120 Formula 2010/
- Maximizing The Benefits Of Optimized Treatment In T2dm 2010/
- The New Emerging Mcc Properties Of Metformin 2010/
- New Emerging Benefits Of B-vitamins In Diabetic Complications 2010/
- The Triple Ham Effects Of Testosterone In Endo-metabolic Link 2010/
- Endo-metabolic Capita Selecta-2010 2010/
- A Decade Of Experiences In Osteoporosis Management With Risedronate 2010/
- Dianeral®: The Novel Fdc Of Cinnulin Pf, Chromium, And Frutafit® Tex 2010/
- Enercore®: The Novel Fdc Of D-ribose, L-carnitine, Coq10, And Mg++ 2010/
- Atorvastatin And Its Multiple Cv Beneficial Properties 2010/
- Innovative Approach Of The Hi-tech Fdc Of Oads To Classical Therapy Of T2dm 2010/
- The New Insights Into Low-fdc Balanced Antioxidant Vitamins, And Micronutrients 2010/
- Dianeral®: The Rationale Fdc Of Cinnulin Pf, Chromium, And Frutafit® Tex 2010/
- The New Management Of Type 2 Diabetes Mellitus 2010/
- The New Emerging Mcc Properties Of Metformin 2010/
- Dianeral®: The Metabolic Fdc Of Cinnulin Pf, Chromium, And Frutafit® Tex 2010/
- Diabetes Mellitus Update And Clinical Experiences: Capita Selecta 2010 2010/
- The Novel Coq10-com And Its Multiple Metabolic Benefits Esp. For Dm And Cvds 2010/
- Galvusmet®: The Novel Fdc Of Vildagliptin And Metformin 2010/
- The Coq10-com®: The Rationale Fdc Of Coq10, L-carnitine, And Ala 2010/
- Graves’ Disease: Diagnosis, Treatment, And Thyroid Storm (ts) 2010/
- Obesity In Indonesia And Its Consequences 2010/
- Diabetologist’s View: B-vitamins’ Effects On Vascular Complications 2010/
- Effects Of Glimepiride On Metabolic – Cardiovascular Risk Factors In Pts With T2dm 2010/
- Practical Guidelines Of Insulin Use In Daily Practice 2010/
- The Coq10-com®: The Novel Fdc Of Coq10, L-carnitine, And Ala 2010/
- The Clinical Use Of Insulin Analogues In Daily Practice 2011/
- Practical Formulas Of Insulin Use In Daily Practice 2011/
- Obesity And Macrophage – Inflammatory Pathway 2011/
- Galvusmet®: The Novel Fdc Of Vildagliptin And Metformin (its Roles On Metabolic Cardiovascular Complications In T2dm) 2011/
- Pleiotropic Effects Of Atorvastatin In Diabetic Vascular Complications 2011/
- Glimepiride Benefits On Metabolic – Cardiovascular Risk Factors In Pts With T2dm 2011/
- Galvusmet®: The Novel Fdc Of Vildagliptin And Metformin 2011/
- Today Clinical Uses Of Novorapid®, Novomix®, And Levemir® 2011/
- Inlacin® : The Novel Insulin Sensitizer With Mecar Effects 2011/
- Amaryl-m®: The Fdc Of Glimepiride And Metformin With Its Mecar Effects 2011/
- Practical Formulas For Guidelines Of Insulin Use In Daily Practice 2011/
- The Roles Of Inlacin In Insulin Resistant Patients With T2dm 2011/
- Amaryl-m®: The Fdc Of Glimepiride And Metformin With Its 16 Benefits 2011/
- Dianeral: Its Clinical Benefits For Patients With Diabetes Mellitus 2011/
- Several Formulas Of Insulin Use In Daily Practice 2011/
- Coq10-com®: The Novel Fdc Of Coq10-60mg, L-carnitine–250mg, And Ala-200mg 2011/
- Janumet®: The Novel Fdc Of Sitagliptin And Metformin 2011/
- Amaryl-m®: The Cardiometabolic Fdc Of Glimepiride And Metformin 2011/
- The Clinical Formulas As Guidelines In Clinical Use Of Insulin Analogues 2011/
- Practical Use Of Insulin Analogues In Daily Practice 2011/
- Inlacin® (dlbs3233) : The Novel Insulin Sensitizer 2011/
- The Incretin Based-therapy In The Treatment Of Patients With T2dm 2011/
- Terapi Non Farmakologi Pada Diabetes Melitus 2011/
- The Novel Fdc Of Coq10, L-carnitine, And Ala In Qten-com 2011/
- Diabetes Mellitus-capita Selecta In Daily Clinical Practice 2011/
- Emergencies In Diabetes Mellitus And Thyroid 2011/
- New Insights Of Metformin In The Treatment Of Diabetes 2011/
- Inlacin® (dlbs 3233): The Novel Insulin Sensitizer With Multiple Unique Mechanisms 2011/
- The Roles Of Vitamin B In Diabetic Vascular Complications 2011/
- Daily Practical Use Of Insulin Analogues Esp. For Outpatients With T2dm 2011/
- Victoza® (liraglutide) : The First Human Glp-1 Analogue 2011/
- Janumet®: The Novel Fdc Of Sitagliptin And Metformin 2011/
- Clinical Uses Of Inlacin® In Daily Practice For Pts With T2dm 2011/
- Obesity And Its Endocardiometabolic Consequences 2011/
- Inlacin® (dlbs3233) : The Novel Insulin Sensitizer With 5 Unique Mechanisms 2011/
- The Importance Of Pmh In The Management Of Patients With T2dm 2011/
- Practical Formulas Of Insulin Analogues In Daily Practice 2011/
- Glycated Hemoglobin (hba1c) And Its Association In Clinical Practice 2012/
- A Critical Appraisal Of Saxagliptin In Daily Practice 2012/
- Obesity: Making Into The Endocardiometabolic World 2012/
- New Therapeutic Strategy In The Treatment Of T2dm 2012/
- Liraglutide (victoza®) : The First Once-daily Human Glp-1 Analogue 2012/
- Inlacin®, The Novel Insulin Sensitizer For Patients With T2dm 2012/
- Incretin-based Therapies In The Management Of T2dm 2012/
- Combination Of Oral Incretin-based Therapies For Patients With T2dm 2012/
- Hypertension And Diabetes The Deadly Conspiration 2008/
- Antioxidant As Pleiotrophic Effect Of Lipid Modulating Drugs (focus: Statins) 2005/
Askandar Tjokroprawiro Agung Pranoto Indropo Agusni David S Perdanakusuma Suhartono Taat Putra Anang Endaryanto Cita Rosita Sigit Prakoeswa Joewono Soeroso Moh. Yasin Ami Ashariati
Role Of Sublingual Immunotheraphy And Probiotics In Clinical Improvements Of Childhood Asthma. [76922]
Perkembangan Otot Dan Saraf Pada Remaja . [73645]
Visit Artikel : 15.237.762
Visit Website : 0
|